Biogen

Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer’s drug PMLiVE12:50Alzheimer's FDA Pharma

Biogen, sarepta quick drug approvals show FDA gaps, report says Mint21:24Alzheimer's FDA Pharma

Sage Therapeutics stock soars as Biogen makes unsolicited takeover bid Investopedia17:18Sage Therapeutics Pharma Biotechnology

Sage Therapeutics shares surge on unsolicited takeover bid from Biogen Proactive Investors (US)16:53Sage Therapeutics Pharma Biotechnology

Biogen CEO sees no burning need for more acquisitions Yahoo! US23:05San Francisco Biotech Pharma

Biogen proposes acquisition of partner Sage Therapeutics Pharmaceutical Technology21:14Depression Biotech Pharma

Biogen offers to buy out wilting Sage for $442 million pharmaphorum09:22Depression Biotech Pharma

Alzheimer's drugs eyed as next big obesity-Like opportunity Yahoo! UK & Ireland11:45Alzheimer's Pharma Health

Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills? Invezz08:52Alzheimer's Pharma Health

At JPM, Biogen CEO tries to take down the deal temperature BioPharma Dive22:44Biotech JPMorgan Chase Pharma

Biogen offers to buy neuroscience firm SAGE for $469 million (1) Bloomberg Law23:41Biotech JPMorgan Chase Pharma

Latest News

In the last 15 minutes

At JPM, Biogen CEO tries to take down the deal temperature BioPharma Dive22:44

Earlier today

Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer’s drug PMLiVE12:50

FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance … JCN Newswire03:00

Yesterday

Biogen CEO sees no burning need for more acquisitions Yahoo! US23:05 14-Jan-25

Biogen, Sarepta Quick Drug Approvals Show FDA Gaps, Report Says Mint21:24 14-Jan-25

Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid Investopedia17:18 14-Jan-25

FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi Benzinga14:14 14-Jan-25

Digital Neuro Biomarkers Market Research 2025-2030, Competitive Analysis of Altoida, Koneksa, Biogen, Roche,… GlobeNewswire (Press Release)14:13 14-Jan-25

Eisai and Biogen’s subcutaneous Leqembi set for FDA review Pharmaceutical Technology12:28 14-Jan-25

FDA sets August date for subcutaneous Leqembi decision pharmaphorum10:26 14-Jan-25

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the… GlobeNewswire (Press Release)00:11 14-Jan-25

In the last 7 days

Biogen proposes acquisition of partner Sage Therapeutics Pharmaceutical Technology21:14 13-Jan-25

Biogen, Moderna, and other Mass. biotech firms making headlines amid JPMorgan Healthcare… Boston Globe21:10 13-Jan-25

Biogen Offers to Buy Remaining Stake in Sage Therapeutics Zacks19:36 13-Jan-25

Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts Benzinga19:16 13-Jan-25

Sage Therapeutics shares surge on unsolicited takeover bid from Biogen Proactive Investors (US)16:53 13-Jan-25

Alzheimer's Drugs Market Report and Forecast 2024-2032, Competitive Analysis of F. Hoffmann-La Roche, Novartis, Merck… GlobeNewswire (Press Release)16:49 13-Jan-25

Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday? Benzinga14:51 13-Jan-25

Biogen CEO confirms he’s shopping for biotechs: ‘We will be doing deals’ Boston Globe14:44 13-Jan-25

Biogen offers to buy out wilting Sage for $442 million pharmaphorum09:22 13-Jan-25

Biogen, already a Sage partner and equity owner, offers to buy the rest of the neuro biotech FiercePharma08:04 13-Jan-25

GSK Kicks Off M&A Push As Deal Speculation And Sunny Skies Set The Scene For J.P. Morgan Scrip Pharma Intelligence07:45 13-Jan-25

Deal Or No Deal? Sage Therapeutics Soars On Acquisition Proposal From Biogen RTT News03:40 11-Jan-25

Biogen offers to buy Sage Therapeutics for $469M ENDPOINTS00:08 11-Jan-25

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen Business Wire (Press Release)23:50 10-Jan-25

Biogen proposes to buy remaining stake in Sage in $442 million deal Yahoo! UK & Ireland23:47 10-Jan-25

Biogen Offers to Buy Neuroscience Firm Sage for $469 Million (1) Bloomberg Law23:41 10-Jan-25

Alzheimer’s Drugs Eyed as Next Big Obesity-Like Opportunity Yahoo! UK & Ireland11:45 10-Jan-25

Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills? Invezz08:52 10-Jan-25

Is the NHS in the drug trial slow lane? Rory Cellan-Jones08:42 10-Jan-25

Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains Yahoo! US05:39 10-Jan-25

Biogen Appoints Adam Feire as Head of Business Development and External Innovation Biogen (Press Release)12:37 9-Jan-25

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer Business Wire (Press Release)13:03 8-Jan-25

In the last month

Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference Biogen (Press Release)21:25 7-Jan-25

Court Rules Biogen Not to Blame for Subtenants’ Woes Banker & Tradesman, Massachusetts16:55 6-Jan-25

Biogen Holds On, But Growth Slips Through Its Fingers Seeking Alpha15:51 4-Jan-25

Biogen Not On Hook For Disruptions Caused By Landlord Law36021:27 3-Jan-25

Beaten Down Biogen Stock Looks Attractive At Current Levels Seeking Alpha20:08 30-Dec-24

Biogen Reportedly Scouts Volpe Move Banker & Tradesman, Massachusetts15:14 20-Dec-24

Netflix, Ford, Biogen: Trending tickers Yahoo! UK & Ireland15:34 16-Dec-24

view more headlines

15 Jan 22:44

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.